Best Treatment Modality of Frozen Shoulder
Shoulder Adhesive Capsulitis ; Comparison Between Three Theraputic Approaches
1 other identifier
interventional
54
1 country
1
Brief Summary
This study will compare between the effect of three treatment modalities of shoulder adhesive capsulitis to hilight the best technique to improve pain and range of motion outcome measures .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 16, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedApril 6, 2022
April 1, 2022
11 months
May 16, 2021
April 5, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Improvement in range of motion of shoulder joint
Improvement will be measured by measuring active and passive range of motion
12 weeks efter intervention
Improvement in pain
Improvement will be measured by VAS ( visual auditory assessment )
12 weeks after intervention
Study Arms (3)
Suprascapular nerve block
ACTIVE COMPARATORThis group will include will under go suprascapularnerve block as following :10 ml of .5% bupivacaine and 2 ml of methylpradnisolon 40mg/ml
Hydrodilatation of shoulder capsule
ACTIVE COMPARATORThis group will undergo intraarticular hydrodilatation by injection of :first lidocaine10ml%followed by 1ml of methylprednisolon 40mg/ml and finally 20ml of .9 % sodium chloride slowly in the gleno humeral joint
Hydrodilatation of shoulder interval
ACTIVE COMPARATORThis group will undergo interval hydrodilatation by injection of :first mepivacaine 10ml folowed by 20ml of sterile water slowly in the shoulder interval
Interventions
Under ultrasound guidance , local shoulder joint injection will be done
Eligibility Criteria
You may qualify if:
- gross limitation of passive shoulder movement
- pain interfering with daily activities
- painful restiction of active and passive movement of shoulder
You may not qualify if:
- presence of degenerative pathology
- fracture
- contraindication to steroid injection
- deformity affecting upper limb
- history of previous shoulder injection in the past 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag faculty
Sohag, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
May 16, 2021
First Posted
May 21, 2021
Study Start
May 1, 2021
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
April 6, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share